| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
-0.68 |
% |
10.6019/CHEMBL4513149 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
31622.8 |
nM |
None |
| Candida albicans |
Candida albicans |
Inhibition |
5.63 |
% |
10.6019/CHEMBL4513149 |
| Candida albicans |
Candida albicans |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Chlorocebus sabaeus |
Vero |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111778 |
| Chlorocebus sabaeus |
Vero |
IC50 |
68.6 |
ug.mL-1 |
10.1021/jm300828h |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-11.17 |
% |
10.6019/CHEMBL4513149 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Escherichia coli |
Escherichia coli |
Inhibition |
9.66 |
% |
10.6019/CHEMBL4513149 |
| Escherichia coli |
Escherichia coli |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Escherichia coli |
Escherichia coli |
MIC90 |
4200.0 |
nM |
10.1021/acs.jmedchem.5b01797 |
| Escherichia coli |
Escherichia coli |
MIC90 |
250000.0 |
nM |
10.1021/acs.jmedchem.5b01797 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ataxin-2 |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
3200.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
12900.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Bile salt export pump |
IC50 |
12900.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
12900.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
28700.0 |
nM |
10.1023/a:1023278211849 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
BT-20 |
IC50 |
19000.0 |
nM |
10.1016/j.ejmech.2021.113562 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
10400.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
21000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
2511.89 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
25999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
8961.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
130.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Eyes absent homolog 2 |
Potency |
1901.5 |
nM |
None |
| Homo sapiens |
Ferrochelatase, mitochondrial |
Inhibition |
nan |
% |
10.6019/CHEMBL3987221 |
| Homo sapiens |
Geminin |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
920.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
34.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 |
Potency |
4610.9 |
nM |
None |
| Homo sapiens |
HEK293 |
CC50 |
310.0 |
nM |
10.6019/CHEMBL4513141 |
| Homo sapiens |
HEK293 |
CC50 |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Homo sapiens |
HERG |
AC50 |
958.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
8562.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.63 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.18 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
Cmax |
4.461 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
Cmax |
1480.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
Css |
0.088 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
T1/2 |
1680.0 |
hr |
10.1016/j.bmc.2014.10.035 |
| Homo sapiens |
Huh-7 |
CC50 |
44700.0 |
nM |
10.1016/j.ejmech.2022.114209 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Importin subunit beta-1/Snurportin-1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
LXR-alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
LXR-beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Lysine-specific demethylase 4A |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
MES-SA |
Activity |
1.8 |
None |
10.1021/jm0491851 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MT4 |
CC50 |
6800.0 |
nM |
10.1016/j.bmc.2014.10.035 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
44500.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
12961.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear receptor subfamily 1 group I member 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
600.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1000.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1100.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
17549.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
Cp |
1.5 |
uM |
10.1016/j.ejmech.2015.01.065 |
| Homo sapiens |
Plasma |
Cp |
2.1 |
uM |
10.1016/j.ejmech.2015.01.065 |
| Homo sapiens |
Plasma |
Cp |
3.0 |
uM |
10.1016/j.ejmech.2015.01.065 |
| Homo sapiens |
Plasma |
Cp |
8.5 |
uM |
10.1016/j.ejmech.2015.01.065 |
| Homo sapiens |
Porphobilinogen deaminase |
Inhibition |
nan |
% |
10.6019/CHEMBL3987221 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Retinoic acid receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Retinoic acid receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Retinoic acid receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
70794.6 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
12995.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
28183.8 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
13.39 |
% |
10.6019/CHEMBL4513149 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Leishmania braziliensis |
Leishmania braziliensis |
IC50 |
nan |
None |
10.1016/j.bmc.2014.11.028 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
950.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
22390.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
4480.0 |
nM |
10.1016/j.bmc.2014.11.028 |
| Leishmania tropica |
Leishmania tropica |
IC50 |
2960.0 |
nM |
10.1016/j.bmc.2014.11.028 |
| Lyssavirus rabies |
Lyssavirus rabies |
EC50 |
2280.0 |
nM |
10.1016/j.ejmech.2022.114209 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm300828h |
| Mus musculus |
Mus musculus |
AUC |
6960.0 |
ng.hr.mL-1 |
10.1021/jm300828h |
| Mus musculus |
Mus musculus |
Cmax |
802.69 |
nM |
10.1021/jm300828h |
| Mus musculus |
Mus musculus |
LD50 |
5.0 |
g/Kg |
10.1016/j.ejmech.2015.01.065 |
| Mus musculus |
Mus musculus |
LD50 |
3000.0 |
mg.kg-1 |
10.1021/jm300828h |
| Mus musculus |
Mus musculus |
T1/2 |
29.74 |
hr |
10.1021/jm300828h |
| Mycobacterium avium |
Mycobacterium avium |
MIC |
4230.0 |
nM |
10.1016/j.bmc.2014.10.035 |
| Mycobacterium avium complex sp. |
Mycobacterium avium complex sp. |
MIC |
0.12 |
ug.mL-1 |
10.1021/np400915p |
| Mycobacterium leprae |
Mycobacterium leprae |
Inhibition |
70.0 |
% |
10.1016/j.bmc.2019.04.032 |
| Mycobacterium leprae |
Mycobacterium leprae |
Inhibition |
94.0 |
% |
10.1016/j.bmc.2019.04.032 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
2.2 |
log10CFU |
10.1021/acs.jmedchem.2c00227 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
nan |
None |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
FC |
2.0 |
None |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
log10cfu |
3.54 |
None |
10.1021/jm300828h |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
log10cfu |
6.33 |
None |
10.1016/j.ejmech.2014.08.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.1 |
ug.mL-1 |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.108 |
ug.mL-1 |
10.1016/j.ejmech.2014.08.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.12 |
ug.mL-1 |
10.1016/j.bmc.2023.117212 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.12 |
ug.mL-1 |
10.1016/j.ejmech.2014.08.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.12 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.12 |
ug.mL-1 |
10.1021/jm300828h |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
0.12 |
ug.mL-1 |
10.1021/np400915p |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1.0 |
ug.mL-1 |
10.1021/acs.jmedchem.9b02075 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1.209 |
ug.mL-1 |
10.1016/j.ejmech.2014.08.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
2.0 |
ug.mL-1 |
10.1016/s0960-894x(03)00241-5 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
125.0 |
nM |
10.1016/j.ejmech.2014.05.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
125.0 |
nM |
10.1016/j.ejmech.2016.11.041 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
250.0 |
nM |
10.1016/j.ejmech.2014.05.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
250.0 |
nM |
10.1016/j.ejmech.2016.11.041 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
500.0 |
nM |
10.1016/j.ejmech.2016.11.041 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
500.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
700.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
800.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1000.0 |
nM |
10.1016/j.ejmech.2014.05.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1060.0 |
nM |
10.1016/j.bmc.2014.10.035 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1500.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
2000.0 |
nM |
10.1016/j.ejmech.2016.11.041 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
8000.0 |
nM |
10.1016/j.ejmech.2014.05.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
16000.0 |
nM |
10.1016/j.ejmech.2014.05.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
200.0 |
nM |
10.1021/acs.jmedchem.1c01383 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
800.0 |
nM |
10.1021/acs.jmedchem.1c01383 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.125 |
uM |
10.1016/j.bmc.2017.08.010 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.125 |
uM |
10.1021/acs.jmedchem.5b00608 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.125 |
uM |
10.1021/acs.jmedchem.9b00912 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.25 |
uM |
10.1016/j.bmc.2017.08.010 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.25 |
uM |
10.1021/acs.jmedchem.5b00608 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.25 |
uM |
10.1021/acs.jmedchem.9b00912 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.5 |
uM |
10.1016/j.bmc.2017.08.010 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.5 |
uM |
10.1021/acs.jmedchem.5b00608 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
0.5 |
uM |
10.1021/acs.jmedchem.9b00912 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
2.0 |
uM |
10.1016/j.bmc.2017.08.010 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
2.0 |
uM |
10.1021/acs.jmedchem.5b00608 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC>99 |
2.0 |
uM |
10.1021/acs.jmedchem.9b00912 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
Activity |
15.0 |
% |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
Activity |
nan |
None |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
MIC |
0.025 |
ug.mL-1 |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
MIC |
0.1 |
ug.mL-1 |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
MIC50 |
200.0 |
nM |
10.1021/acs.jmedchem.1c01383 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
MIC90 |
400.0 |
nM |
10.1021/acs.jmedchem.1c01383 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Concentration |
0.5 |
ug ml-1 |
10.1021/jm00398a013 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Concentration |
1.5 |
ug ml-1 |
10.1021/jm00398a013 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Concentration |
30.0 |
ug ml-1 |
10.1021/jm00398a013 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC>90 |
1.1 |
ug ml-1 |
10.1021/np400145u |
| Naegleria gruberi |
Naegleria gruberi |
Inhibition |
67.9 |
% |
10.6019/CHEMBL4513101 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4100.0 |
nM |
10.6019/CHEMBL3392926 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4820.0 |
nM |
10.1016/j.bmc.2014.11.028 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7020.0 |
nM |
10.1016/j.bmc.2014.11.028 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2869.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
5102.8 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Ratio IC50 |
1.5 |
None |
10.1016/j.bmc.2014.11.028 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
6.99 |
% |
10.6019/CHEMBL4513149 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC90 |
8400.0 |
nM |
10.1021/acs.jmedchem.5b01797 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC90 |
250000.0 |
nM |
10.1021/acs.jmedchem.5b01797 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
29000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
H9c2 |
Activity |
nan |
None |
10.1016/j.ejmech.2015.01.065 |
| Rattus norvegicus |
INS1 |
AC50 |
2058.0 |
nM |
None |
| Rattus norvegicus |
Liver |
IC50 |
nan |
None |
10.1002/hep.27206 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
6911.1 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
5000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.66 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
21.09 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
EC50 |
10000.0 |
nM |
10.1016/j.ejmech.2022.114209 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.5936 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.37 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.51 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
4.74 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.1058 |
None |
10.1101/2020.04.03.023846 |
| Severe acute respiratory syndrome coronavirus 2 |
Spike glycoprotein |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114209 |
| Severe acute respiratory syndrome coronavirus 2 |
Spike glycoprotein |
Kd |
3820.0 |
nM |
10.1016/j.ejmech.2022.114209 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
59.44 |
% |
10.6019/CHEMBL4513149 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Streptococcus |
Streptococcus |
EC50 |
36884.0 |
nM |
None |
| Streptococcus pyogenes serotype M1 |
Streptokinase A |
EC50 |
1243.0 |
nM |
None |
| Streptococcus pyogenes serotype M1 |
Streptokinase A |
EC50 |
2281.0 |
nM |
None |
| Streptococcus sp. 'group A' |
Streptococcus sp. 'group A' |
EC50 |
1862.0 |
nM |
None |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
7630.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma cruzi |
Cruzipain |
IC50 |
6000.0 |
nM |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Cruzipain |
IC50 |
6000.0 |
nM |
10.1021/jm100254w |
| Trypanosoma cruzi |
Cruzipain |
IC50 |
40000.0 |
nM |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Cruzipain |
IC50 |
40000.0 |
nM |
10.1021/jm100254w |
| Trypanosoma cruzi |
Cruzipain |
Inhibition |
nan |
% |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Activity |
0.0 |
% |
10.1016/j.ejmech.2019.111778 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Activity |
1.0 |
None |
10.1016/j.ejmech.2019.111778 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Activity |
nan |
None |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111778 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
FC |
3.0 |
None |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
38230.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Inhibition |
40.0 |
% |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
Inhibition |
nan |
% |
10.1016/j.ejmech.2015.01.065 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
LC50 |
10600.0 |
nM |
10.1016/j.ejmech.2015.01.065 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111778 |
| None |
ADMET |
CC50 |
18600.0 |
nM |
10.1016/j.bmc.2014.10.035 |
| None |
ADMET |
CC50 |
100000.0 |
nM |
10.1016/j.bmc.2014.10.035 |
| None |
ADMET |
IC50 |
18590.0 |
nM |
10.1016/j.bmc.2014.11.028 |
| None |
ADMET |
PPB |
99.63 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Selectivity Index |
4.5 |
None |
10.1016/j.ejmech.2022.114209 |
| None |
ADMET |
Selectivity Index |
141.0 |
None |
10.1016/j.ejmech.2022.114209 |
| None |
Erythrocyte |
HC10 |
20.0 |
uM |
10.6019/CHEMBL4513161 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
76.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
51.3 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
3.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
25.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
76.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
102.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
fAUC/MIC |
1.0 |
None |
10.1016/j.bmcl.2013.07.006 |
| None |
NON-PROTEIN TARGET |
fCmax/MIC |
0.02 |
None |
10.1016/j.bmcl.2013.07.006 |
| None |
NON-PROTEIN TARGET |
fT>MIC |
0.0 |
% |
10.1016/j.bmcl.2013.07.006 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
5.6 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
16.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
6340.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
9970.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
10650.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
Potency |
6.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
1495.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
RatioAUC/MIC |
20.0 |
None |
10.1016/j.bmcl.2013.07.006 |
| None |
NON-PROTEIN TARGET |
%T>MIC |
0.0 |
% |
10.1016/j.bmcl.2013.07.006 |
| None |
No relevant target |
Activity |
10.0 |
uM |
10.1021/jm100254w |
| None |
No relevant target |
Activity |
103.7 |
nm |
10.1021/jm100254w |
| None |
No relevant target |
Activity |
356.1 |
nm |
10.1021/jm100254w |
| None |
No relevant target |
Activity |
600.0 |
uM |
10.1021/jm100254w |
| None |
No relevant target |
Activity |
nan |
None |
10.1021/jm100254w |
| None |
No relevant target |
LogD |
6.36 |
None |
10.1016/j.bmc.2014.10.035 |
| None |
No relevant target |
LogD7.4 |
3.17 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
5.34 |
None |
10.1021/jm300828h |
| None |
No relevant target |
pKa_B1 |
8.8 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
700.0 |
nM |
10.6019/CHEMBL3301361 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Activity |
88.0 |
% |
10.1021/acsmedchemlett.0c00521 |
| None |
Unchecked |
Average IC90 |
0.23 |
uM |
None |
| None |
Unchecked |
Average IC90 |
0.31 |
uM |
None |
| None |
Unchecked |
Average IC90 |
0.36 |
uM |
None |
| None |
Unchecked |
Average IC90 |
0.396 |
uM |
None |
| None |
Unchecked |
CC50 |
2200.0 |
nM |
None |
| None |
Unchecked |
CC50 |
4700.0 |
nM |
None |
| None |
Unchecked |
CC50 |
10200.0 |
nM |
None |
| None |
Unchecked |
CC50 |
323000.0 |
nM |
10.1016/j.ejmech.2022.114209 |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
391.0 |
nM |
None |
| None |
Unchecked |
IC50 |
6000.0 |
nM |
10.1016/j.ejmech.2020.112275 |
| None |
Unchecked |
IC50 |
7000.0 |
nM |
10.1016/j.ejmech.2020.112275 |
| None |
Unchecked |
IC50 |
7200.0 |
nM |
10.1016/j.ejmech.2021.113562 |
| None |
Unchecked |
IC50 |
600000.0 |
nM |
10.1021/acsmedchemlett.0c00521 |
| None |
Unchecked |
Kd |
280.0 |
nM |
10.1016/j.ejmech.2022.114209 |
| None |
Unchecked |
Potency |
3381.4 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Ratio |
0.002 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.004 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.007 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.008 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
1.0 |
None |
10.1016/j.bmcl.2013.07.006 |
| None |
Unchecked |
Ratio IC50 |
2.6 |
None |
10.1016/j.bmc.2014.11.028 |
| None |
Unchecked |
Ratio IC50 |
2.6 |
None |
10.1016/j.ejmech.2021.113562 |
| None |
Unchecked |
Ratio IC50 |
3.9 |
None |
10.1016/j.bmc.2014.11.028 |
| None |
Unchecked |
Ratio IC50 |
4.2 |
None |
10.1016/j.bmc.2014.11.028 |
| None |
Unchecked |
Ratio IC50 |
6.3 |
None |
10.1016/j.bmc.2014.11.028 |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.bmc.2014.11.028 |
| None |
Unchecked |
Selectivity Index |
6.41 |
None |
10.1016/j.bmc.2014.10.035 |
| None |
Unchecked |
Selectivity Index |
17.55 |
None |
10.1016/j.bmc.2014.10.035 |
| None |
Unchecked |
Selectivity Index |
94.0 |
None |
10.1016/j.bmc.2014.10.035 |
| None |
Unchecked |
Selectivity Index |
572.0 |
None |
10.1021/jm300828h |